DE69418368T2 - Peptidderivate aus Boronsäure mit Protease-inhibierender Aktivität, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

Peptidderivate aus Boronsäure mit Protease-inhibierender Aktivität, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69418368T2
DE69418368T2 DE69418368T DE69418368T DE69418368T2 DE 69418368 T2 DE69418368 T2 DE 69418368T2 DE 69418368 T DE69418368 T DE 69418368T DE 69418368 T DE69418368 T DE 69418368T DE 69418368 T2 DE69418368 T2 DE 69418368T2
Authority
DE
Germany
Prior art keywords
hydrogen atom
group
borononic
pharmaceutical compositions
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69418368T
Other languages
English (en)
Other versions
DE69418368D1 (de
Inventor
Nanteuil Guillaume De
Christine Lila
Michel Laubie
Tony Verbeuren
Serge Simonet
Alain Rupin
Bernard Portevin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69418368D1 publication Critical patent/DE69418368D1/de
Application granted granted Critical
Publication of DE69418368T2 publication Critical patent/DE69418368T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69418368T 1993-02-24 1994-02-24 Peptidderivate aus Boronsäure mit Protease-inhibierender Aktivität, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE69418368T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302082A FR2701951B1 (fr) 1993-02-24 1993-02-24 Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
DE69418368D1 DE69418368D1 (de) 1999-06-17
DE69418368T2 true DE69418368T2 (de) 1999-12-16

Family

ID=9444358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418368T Expired - Fee Related DE69418368T2 (de) 1993-02-24 1994-02-24 Peptidderivate aus Boronsäure mit Protease-inhibierender Aktivität, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (14)

Country Link
US (1) US5444049A (de)
EP (1) EP0615978B1 (de)
JP (1) JP2533290B2 (de)
AT (1) ATE179988T1 (de)
AU (1) AU666801B2 (de)
CA (1) CA2116181A1 (de)
DE (1) DE69418368T2 (de)
DK (1) DK0615978T3 (de)
ES (1) ES2133504T3 (de)
FR (1) FR2701951B1 (de)
GR (1) GR3030311T3 (de)
HK (1) HK1010378A1 (de)
NZ (1) NZ250957A (de)
ZA (1) ZA941273B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
FR2721611B1 (fr) * 1994-06-22 1996-09-27 Adir Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
US5639739A (en) * 1995-03-24 1997-06-17 The Dupont Merck Pharmaceutical Company Imidazole containing aminoboronic acids
EP0846682B9 (de) 1995-07-26 2003-05-14 Mitsubishi Chemical Corporation Penizillaminamid-derivate
FR2739858B1 (fr) * 1995-10-11 1997-11-14 Synthelabo Derives de n-sulfonyl- et n-sulfamoylpeptidylprolinamide, leur preparation et leur application en therapeutique
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
FR2758329B1 (fr) * 1997-01-16 1999-02-12 Synthelabo Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
US6040145A (en) * 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
KR100458403B1 (ko) * 1997-09-29 2004-11-26 포인트 써러퓨틱스, 인크. 생체외 조혈세포의 자극방법
EP1075266A1 (de) * 1998-05-04 2001-02-14 Point Therapeutics, Inc. Hämatopoietische stimulierung
PT1084129E (pt) 1998-06-05 2003-06-30 Point Therapeutics Inc Compostos de boroprolina ciclica
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
FR2793248B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
CA2441201A1 (en) 2001-03-19 2002-10-03 Fujimori Kogyo Co., Ltd. Thrombin and anhydrothrombin with modified carboxyl groups
EP1578434A2 (de) * 2002-07-09 2005-09-28 Point Therapeutics, Inc. Verfahren und zusammensetzung in bezug auf isoleucin-boroprolin-verbindungen
DK1400245T3 (da) * 2002-09-09 2006-08-28 Trigen Ltd Borsyresalte anvendelige til parenterale formuleringer til selektiv thrombininhibering
US20050282757A1 (en) * 2002-09-09 2005-12-22 Trigen Limited Peptide boronic acid compounds useful in anticoagulation
US20060084592A1 (en) * 2002-09-09 2006-04-20 Trigen Limited Peptide boronic acid inhibitors
US20050119226A1 (en) * 2003-09-09 2005-06-02 Trigen Limited Methods for synthesizing organoboronic compounds and products thereof
US20050176651A1 (en) * 2002-09-09 2005-08-11 Trigen Limited Peptide boronic acids useful in making salts thereof
US7112572B2 (en) * 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
GB0405272D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
JP2024511979A (ja) 2021-03-15 2024-03-18 メイズ セラピューティクス, インコーポレイテッド グリコーゲンシンターゼ1(gys1)の阻害剤及びその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) * 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0615978B1 (de) 1999-05-12
AU5630294A (en) 1994-09-01
HK1010378A1 (en) 1999-06-17
JP2533290B2 (ja) 1996-09-11
US5444049A (en) 1995-08-22
GR3030311T3 (en) 1999-09-30
DE69418368D1 (de) 1999-06-17
NZ250957A (en) 1995-09-26
JPH06298795A (ja) 1994-10-25
DK0615978T3 (da) 1999-11-15
FR2701951A1 (fr) 1994-09-02
FR2701951B1 (fr) 1995-06-09
EP0615978A1 (de) 1994-09-21
CA2116181A1 (fr) 1994-08-25
ZA941273B (en) 1994-10-19
AU666801B2 (en) 1996-02-22
ATE179988T1 (de) 1999-05-15
ES2133504T3 (es) 1999-09-16

Similar Documents

Publication Publication Date Title
DE69418368T2 (de) Peptidderivate aus Boronsäure mit Protease-inhibierender Aktivität, ihr Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen
HUP0100669A2 (hu) Szerin proteázokat gátló peptidszármazékok és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
WO2003059880A1 (fr) Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
NO930517L (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
AU617875B2 (en) Novel peptidase inhibitors
YU65804A (sh) Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze
TR199601032A2 (tr) Matris metalloprotaz önleyicileri.
HUP0301249A2 (hu) APO B termelődés gátló benzamid-vegyületek ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP0670309A4 (de) Verbindung mit prolye-endopeptidase inhibierender aktivität und ihre pharmazeutische verwendung.
GEP20033028B (en) Heterocyclic Compounds as Inhibitors of Rotamase Enzymes, Method for Their Production, Pharmaceutical Composition Containing Them and Use Thereof
HUP0002404A2 (hu) Aminosavszármazékok, hatóanyagként ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
FI960149A0 (fi) Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä
ATE199909T1 (de) Derivate der phosphonsäure, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
FI891712A0 (fi) Terapeutiskt aktiva aminer av cyklometylen-1,2-bikarboxylsyror, foerfaranden foer deras framstaellning samt farmaceutiska kompositioner innehaollande dem.
Su et al. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors
ES463557A2 (es) Procedimiento para la preparacion de amidas aromaticas de compuestos heterociclicos.
UA48050A1 (uk) N-(4-фенілтіазоліл-2)-сукцинамоїлгідроксамова кислота, яка проявляє протизапальну активність

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee